Showing results (831-840 of 9,402) with videos related to
Sort By:
Pageof 941
Clinical Pharmacology and Therapeutics|February 4, 2011
Subjective and physiological effects after controlled Sativex and oral THC administrationE L Karschner, W D Darwin, R P McMahon, et al.Clinical Pharmacology and Therapeutics|February 4, 2011
Pharmacogenomics of the RNA world: structural RNA polymorphisms in drug therapyW Sadee, D Wang, A C Papp, et al.Clinical Pharmacology and Therapeutics|January 29, 2011
Induction of opioid-dependent individuals onto buprenorphine and buprenorphine/naloxone soluble-filmsE C Strain, J A Harrison, G E BigelowClinical Pharmacology and Therapeutics|January 29, 2011
Clinical Pharmacogenetics Implementation Consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosingM V Relling, E E Gardner, W J Sandborn, et al.Clinical Pharmacology and Therapeutics|March 4, 2011
Benzodiazepine-like hypnotics and the associated risk of road traffic accidentsL Orriols, P Philip, N Moore, et al.Clinical Pharmacology and Therapeutics|January 22, 2011
The emergency use authorization of peramivir IV: a view from the manufacturerA S Hollister, W P SheridanClinical Pharmacology and Therapeutics|October 21, 2010
Impact of the new US health-care-reform legislation on the pharmaceutical industry: who are the real winners?C-P Milne, K I KaitinClinical Pharmacology and Therapeutics|October 21, 2010
The enrichment window approach as a means of dealing with placebo response in antidepressant clinical trialsC H Mallinckrodt, W R PruckaClinical Pharmacology and Therapeutics|October 15, 2010
Probabilistic risk analysis: improving early drug development decision makingP N Mudd, H Groenendaal, M A Bush, et al.Clinical Pharmacology and Therapeutics|September 22, 2010
MDR1-P-glycoprotein (ABCB1)-mediated disposition of amyloid-β peptides: implications for the pathogenesis and therapy of Alzheimer's diseaseG Jedlitschky, S Vogelgesang, H K KroemerPageof 941